Because the four letters of correspondence describe a variety of concerns, I have
organized them according to their general topic and in some instances re-emphasized
data from the original reports (
1
,
2
,
3
).To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Academic RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Effect of three decades of screening mammography on the incidence of breast cancer.NEJM. 2012; 367: 1998-2005
- Were our estimates of overdiagnosis with mammography screening in the United States “based on faulty science?”.Oncologist. 2014; 19: 113-126
- Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.Acad Radiol. 2015; 22: 949-960
- Reply to flawed assumptions used to defend screening mammography.Cancer. 2015; 121: 321-323
- Forty-five years of cancer incidence in Connecticut: 1935–1979.Natl Cancer Inst Monogr. 1986; 70: 1-706
- Using mammography for cancer control: an unrealized potential.CA Cancer J Clin. 1987; 37: 33-48
- The status of breast cancer screening: a quarter of a century of research.World J Surg. 1989; 13: 9-18
- Cancer incidence and mortality trends among whites in the United States, 1947-84.J Natl Cancer Inst. 1987; 79: 701-770
- Position paper: breast cancer screening, diagnosis, and treatment in Denmark.Acta Oncol. 2014; 53: 433-444
- Population-based service mammography screening: the Icelandic experience.Breast Cancer (Dove Med Press). 2013; 5: 17
- Demographics of Iceland.(Available at:) (Accessed August 3, 2015)
- Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis.J Natl Cancer Inst Monogr. 2006; : 112-121
- Epidemiology of breast cancer in young women.Breast Dis. 2005-2006; 23: 3-8
- Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.Lancet. 2002; 360: 187-195
- Breast cancer, pregnancy, and breastfeeding.J Obstet Gynaecol Can. 2002; 24: 164-180
- A reality check for overdiagnosis estimates associated with breast cancer screening.J Natl Cancer Inst. 2014; 106
- Lead time and overdiagnosis.J Natl Cancer Inst. 2014; 106: dju346https://doi.org/10.1093/jnci/dju346
- Use of mammography among women 40 years of age and over, by selected characteristics: United States, selected years 1987–2008.(Table 86 (page 1 of 3). Atlanta: Centers for Disease Control and Prevention. Available at:) (Accessed August 4, 2015)
- Breast Cancer Surveillance Consortium mammography data.(Available at:) (Accessed August 4, 2015)
- Counterpoint: the New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically correct and should not be withdrawn.J Am Coll Radiol. 2013; 10: 320-323
- Surveillance, Epidemiology, and End Results (SEER) Program.(SEER*Stat Database: Incidence—SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973-2012 varying)—Linked To County Attributes—Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission. Available at:) (Accessed August 4, 2015)
- The balance is shifting away from screening.Clin Adv Hematol Oncol. 2014; 12: 407-409
- Breast cancer screening, incidence, and mortality across U.S. counties.JAMA Intern Med. 2015; 175 (Published online July 6, 2015): 1483-1489
- Appendix of randomized controlled trials.(Available at) (Accessed August 4, 2015)
- Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.BMJ. 2014; 348: g366
- Screening for breast cancer with mammography (Review).Cochrane Database Syst Rev. 2011; (CD001877)
- Sorting through the arguments on breast screening.JAMA. 2013; 309: 2553-2554
- Screening for breast and prostate cancers. Moving toward transparency.J Natl Cancer Inst. 2010; 102: 1008-1011
- Breast cancer screening for health professionals: Benefits of screening: Randomized controlled trials; Summary.(Available at:) (Accessed August 4, 2015)
- Screening mammography in older women: a review.JAMA. 2014; 311: 1336-1347
- Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.BMJ. 2013; 346: e8441
- The medical aspects of carcinoma of the breast, with a note on the spontaneous disappearance of secondary growths.Amer Med Phila. 1901; 17: 63-66
- An address on the medical aspects of carcinoma of the breast.Br Med J. 1906; 1: 1-4
- Fluctuations in the growth energy of tumors in man, with special reference to spontaneous recession.J Cancer Res. 1918; 3: 193-225
- Spontaneous cancer cures and regressions.Rev Prat. 1964; 14 (in French): 2177-2180
- The spontaneous regression of cancer. A review of cases from 1900 to 1987.Acta Oncol. 1990; 29: 545-550
- Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.Br J Cancer. 1987; 56: 814-819
- Cancer Query System: probability of developing or dying of cancer.(Available at:) (Accessed August 3, 2015)
- Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women.Br J Cancer. 1985; 51: 271-278
- The prevalence of carcinoma in situ in normal and cancer-associated breasts.Hum Pathol. 1985; 16: 796-807
- Breast screening: helping you decide.(National Health Service. NHS Cancer Screening Programmes 2901195, pp. 9–11. Available at:) (Accessed August 4, 2015)
- Research-based evaluation of the Norwegian Breast Cancer Screening Program Final report.(The Research Council of Norway, Oslo, May; p. 9. Available at:) (Accessed August 4, 2015)
- Substitute “prostate cancer” for “neuroblastoma?”.J Clin Oncol. 2002; 20: 1154-1155
- Overdiagnosis in low-dose computed tomography screening for lung cancer.JAMA Intern Med. 2014; 174: 269-274
- The “epidemic” of melanoma between under- and overdiagnosis.J Cutan Pathol. 2012; 39: 9-16
- Lead-time and overdiagnosis estimation in neuroblastoma screening.Stat Med. 2003; 22: 2877-2892
- Overdiagnosis and overtreatment of prostate cancer.Eur Urol. 2014; 65: 1046-1055
- Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.Int J Cancer. 2015; 137: 2664-2673
Article info
Publication history
Published online: November 05, 2015
Footnotes
In reply to Reich and Kim.
Identification
Copyright
© 2016 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.